{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T03:07:40Z","timestamp":1792638460690,"version":"4.5.0"},"reference-count":45,"publisher":"American Medical Association (AMA)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Netw Open"],"DOI":"10.1001\/jamanetworkopen.2021.0070","type":"journal-article","created":{"date-parts":[[2021,2,24]],"date-time":"2021-02-24T12:24:46Z","timestamp":1614169486000},"page":"e210070","source":"Crossref","is-referenced-by-count":85,"title":["Assessment and Management of Cardiovascular Risk Factors Among US Veterans With Prostate Cancer"],"prefix":"10.1001","volume":"4","author":[{"given":"Lova","family":"Sun","sequence":"first","affiliation":[{"name":"Division of Hematology\/Oncology, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia"},{"name":"Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ravi B.","family":"Parikh","sequence":"additional","affiliation":[{"name":"Department of Hematology\/Oncology, Corporal Michael J. Crescenz Veterans Affairs Medical Center, Philadelphia, Pennsylvania"},{"name":"Department of Medical Ethics and Health Policy, Perelman School of Medicine, University of Pennsylvania, Philadelphia"},{"name":"Center for Health Equity Research and Promotion, Veterans Affairs Pittsburgh Healthcare System, Pittsburgh, Pennsylvania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca A.","family":"Hubbard","sequence":"additional","affiliation":[{"name":"Department of Biostatistics, Epidemiology & Informatics, Perelman School of Medicine, University of Pennsylvania, Philadelphia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Cashy","sequence":"additional","affiliation":[{"name":"Center for Health Equity Research and Promotion, Veterans Affairs Pittsburgh Healthcare System, Pittsburgh, Pennsylvania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel U.","family":"Takvorian","sequence":"additional","affiliation":[{"name":"Division of Hematology\/Oncology, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia"},{"name":"Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David J.","family":"Vaughn","sequence":"additional","affiliation":[{"name":"Division of Hematology\/Oncology, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia"},{"name":"Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyle W.","family":"Robinson","sequence":"additional","affiliation":[{"name":"Division of Hematology\/Oncology, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia"},{"name":"Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia"},{"name":"Department of Hematology\/Oncology, Corporal Michael J. Crescenz Veterans Affairs Medical Center, Philadelphia, Pennsylvania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vivek","family":"Narayan","sequence":"additional","affiliation":[{"name":"Division of Hematology\/Oncology, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia"},{"name":"Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bonnie","family":"Ky","sequence":"additional","affiliation":[{"name":"Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia"},{"name":"Department of Biostatistics, Epidemiology & Informatics, Perelman School of Medicine, University of Pennsylvania, Philadelphia"},{"name":"Division of Cardiology, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","published-online":{"date-parts":[[2021,2,24]]},"reference":[{"issue":"3","key":"zoi210008r1","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.urolonc.2019.10.006","article-title":"Improving research for prostate cancer survivorship: A statement from the Survivorship Research in Prostate Cancer (SuRECaP) working group.","volume":"38","author":"Narayan","year":"2020","journal-title":"Urol Oncol"},{"key":"zoi210008r2","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1200\/JCO.2020.38.6_suppl.364","article-title":"The prevalence of cardiovascular disease and its risk factors among prostate cancer patients treated with and without androgen deprivation","volume":"38","author":"Pinthus","year":"2020","journal-title":"J Clin Oncol"},{"issue":"1","key":"zoi210008r3","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.ijrobp.2018.07.2018","article-title":"Cardiovascular preventive care and coordination of care in prostate cancer survivors: a multi-institutional prospective study.","volume":"103","author":"Holmes","year":"2019","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"12","key":"zoi210008r4","doi-asserted-by":"publisher","first-page":"1868","DOI":"10.1200\/JCO.2005.04.7423","article-title":"Immediate or deferred androgen deprivation for patients with prostate cancer not suitable for local treatment with curative intent: European Organisation for Research and Treatment of Cancer (EORTC) Trial 30891.","volume":"24","author":"Studer","year":"2006","journal-title":"J Clin Oncol"},{"issue":"6","key":"zoi210008r5","doi-asserted-by":"publisher","first-page":"1269","DOI":"10.1016\/j.eururo.2009.02.016","article-title":"Intermittent androgen deprivation for locally advanced and metastatic prostate cancer: results from a randomised phase 3 study of the South European Uroncological Group.","volume":"55","author":"Calais da Silva","year":"2009","journal-title":"Eur Urol"},{"issue":"1","key":"zoi210008r6","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1038\/pcan.2011.55","article-title":"Cause-specific mortality following radical prostatectomy.","volume":"15","author":"Shikanov","year":"2012","journal-title":"Prostate Cancer Prostatic Dis"},{"issue":"11","key":"zoi210008r7","doi-asserted-by":"publisher","first-page":"1104","DOI":"10.1161\/CIRCULATIONAHA.115.020406","article-title":"Shared risk factors in cardiovascular disease and cancer.","volume":"133","author":"Koene","year":"2016","journal-title":"Circulation"},{"issue":"27","key":"zoi210008r8","doi-asserted-by":"publisher","first-page":"4448","DOI":"10.1200\/JCO.2006.06.2497","article-title":"Diabetes and cardiovascular disease during androgen deprivation therapy for prostate cancer.","volume":"24","author":"Keating","year":"2006","journal-title":"J Clin Oncol"},{"issue":"1","key":"zoi210008r9","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1093\/jnci\/djp404","article-title":"Diabetes and cardiovascular disease during androgen deprivation therapy: observational study of veterans with prostate cancer.","volume":"102","author":"Keating","year":"2010","journal-title":"J Natl Cancer Inst"},{"issue":"7","key":"zoi210008r10","doi-asserted-by":"publisher","first-page":"1493","DOI":"10.1002\/(ISSN)1097-0142","article-title":"Androgen deprivation therapy increases cardiovascular morbidity in men with prostate cancer.","volume":"110","author":"Saigal","year":"2007","journal-title":"Cancer"},{"issue":"24","key":"zoi210008r11","doi-asserted-by":"publisher","first-page":"3979","DOI":"10.1200\/JCO.2006.05.9741","article-title":"Metabolic syndrome in men with prostate cancer undergoing long-term androgen-deprivation therapy.","volume":"24","author":"Braga-Basaria","year":"2006","journal-title":"J Clin Oncol"},{"issue":"11","key":"zoi210008r12","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.1200\/JCO.2014.59.1792","article-title":"Risk and timing of cardiovascular disease after androgen-deprivation therapy in men with prostate cancer.","volume":"33","author":"O\u2019Farrell","year":"2015","journal-title":"J Clin Oncol"},{"key":"zoi210008r13","doi-asserted-by":"publisher","first-page":"820403","DOI":"10.1155\/2015\/820403","article-title":"The prevalence of cardiac risk factors in men with localized prostate cancer undergoing androgen deprivation therapy in British Columbia, Canada.","volume":"2015","author":"Davis","year":"2015","journal-title":"J Oncol"},{"issue":"6","key":"zoi210008r14","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1161\/CIRCULATIONAHA.109.192695","article-title":"Androgen-deprivation therapy in prostate cancer and cardiovascular risk: a science advisory from the American Heart Association, American Cancer Society, and American Urological Association: endorsed by the American Society for Radiation Oncology.","volume":"121","author":"Levine","year":"2010","journal-title":"Circulation"},{"issue":"5","key":"zoi210008r15","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1161\/CIRCULATIONAHA.115.012519","article-title":"Cardiovascular effects of androgen deprivation therapy for the treatment of prostate cancer: ABCDE steps to reduce cardiovascular disease in patients with prostate cancer.","volume":"133","author":"Bhatia","year":"2016","journal-title":"Circulation"},{"issue":"1","key":"zoi210008r16","doi-asserted-by":"publisher","first-page":"153","DOI":"10.3233\/JPD-171271","article-title":"Cardiovascular risk factor burden in veterans and non-veterans with Parkinson disease.","volume":"8","author":"Kotagal","year":"2018","journal-title":"J Parkinsons Dis"},{"issue":"103","key":"zoi210008r17","first-page":"1","article-title":"Prevalence of uncontrolled risk factors for cardiovascular disease: United States, 1999-2010.","author":"Fryar","year":"2012","journal-title":"NCHS Data Brief"},{"issue":"6","key":"zoi210008r18","first-page":"703","article-title":"Veterans and risk of heart disease in the United States: a cohort with 20 years of follow up.","volume":"5","author":"Assari","year":"2014","journal-title":"Int J Prev Med"},{"issue":"25","key":"zoi210008r20","doi-asserted-by":"publisher","first-page":"S49","DOI":"10.1161\/01.cir.0000437741.48606.98","article-title":"2013 ACC\/AHA guideline on the assessment of cardiovascular risk: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines.","volume":"129","author":"Goff","year":"2014","journal-title":"Circulation"},{"issue":"22","key":"zoi210008r21","doi-asserted-by":"publisher","first-page":"2458","DOI":"10.1161\/CIR.0b013e318235eb4d","article-title":"AHA\/ACCF secondary prevention and risk reduction therapy for patients with coronary and other atherosclerotic vascular disease: 2011 update: a guideline from the American Heart Association and American College of Cardiology Foundation.","volume":"124","author":"Smith","year":"2011","journal-title":"Circulation"},{"issue":"25, pt B","key":"zoi210008r22","doi-asserted-by":"publisher","first-page":"2889","DOI":"10.1016\/j.jacc.2013.11.002","article-title":"2013 ACC\/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines.","volume":"63","author":"Stone","year":"2014","journal-title":"J Am Coll Cardiol"},{"issue":"6","key":"zoi210008r23","doi-asserted-by":"publisher","first-page":"1206","DOI":"10.1161\/01.HYP.0000107251.49515.c2","article-title":"Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure.","volume":"42","author":"Chobanian","year":"2003","journal-title":"Hypertension"},{"key":"zoi210008r24","doi-asserted-by":"publisher","first-page":"S11","DOI":"10.2337\/dc10-S011","article-title":"Standards of medical care in diabetes\u20132010.","volume":"33","author":"American Diabetes Association","year":"2010","journal-title":"Diabetes Care"},{"issue":"5","key":"zoi210008r25","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.114.001035","article-title":"HIV infection and cardiovascular disease in women.","volume":"3","author":"Womack","year":"2014","journal-title":"J Am Heart Assoc"},{"issue":"1","key":"zoi210008r26","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1002\/(ISSN)1527-3350","article-title":"Risk of diabetes in HIV infected veterans pre- and post-HAART and the role of HCV coinfection.","volume":"40","author":"Butt","year":"2004","journal-title":"Hepatology"},{"issue":"2","key":"zoi210008r27","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1097\/QAI.0000000000000419","article-title":"HIV infection, cardiovascular disease risk factor profile, and risk for acute myocardial infarction.","volume":"68","author":"Paisible","year":"2015","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"7","key":"zoi210008r28","doi-asserted-by":"publisher","first-page":"e196562","DOI":"10.1001\/jamanetworkopen.2019.6562","article-title":"Association between androgen deprivation therapy use and diagnosis of dementia in men with prostate cancer.","volume":"2","author":"Jayadevappa","year":"2019","journal-title":"JAMA Netw Open"},{"issue":"10","key":"zoi210008r29","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1097\/MLR.0b013e31822396c5","article-title":"Reliance on Veterans Affairs outpatient care by Medicare-eligible veterans.","volume":"49","author":"Liu","year":"2011","journal-title":"Med Care"},{"issue":"10","key":"zoi210008r30","doi-asserted-by":"publisher","first-page":"1050","DOI":"10.1111\/j.1525-1497.2006.00519.x","article-title":"Simultaneous control of intermediate diabetes outcomes among Veterans Affairs primary care patients.","volume":"21","author":"Jackson","year":"2006","journal-title":"J Gen Intern Med"},{"issue":"4","key":"zoi210008r31","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1001\/jamacardio.2018.0005","article-title":"The 2017 American College of Cardiology\/American Heart Association clinical practice guideline for high blood pressure in adults.","volume":"3","author":"Whelton","year":"2018","journal-title":"JAMA Cardiol"},{"issue":"8","key":"zoi210008r32","doi-asserted-by":"publisher","first-page":"569","DOI":"10.7326\/M17-0939","article-title":"Hemoglobin A1c targets for glycemic control with pharmacologic therapy for nonpregnant adults with type 2 diabetes mellitus: a guidance statement update from the American College of Physicians.","volume":"168","author":"Qaseem","year":"2018","journal-title":"Ann Intern Med"},{"issue":"8","key":"zoi210008r33","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1161\/CIRCULATIONAHA.118.035550","article-title":"Sex differences in the prevalence of, and trends in, cardiovascular risk factors, treatment, and control in the United States, 2001 to 2016.","volume":"139","author":"Peters","year":"2019","journal-title":"Circulation"},{"issue":"11","key":"zoi210008r34","doi-asserted-by":"publisher","first-page":"1337","DOI":"10.1093\/aje\/kwm223","article-title":"A modified least-squares regression approach to the estimation of risk difference.","volume":"166","author":"Cheung","year":"2007","journal-title":"Am J Epidemiol"},{"issue":"26","key":"zoi210008r35","doi-asserted-by":"publisher","first-page":"2456","DOI":"10.1056\/NEJMp1802313","article-title":"Making neighborhood-disadvantage metrics accessible\u2014the neighborhood atlas.","volume":"378","author":"Kind","year":"2018","journal-title":"N Engl J Med"},{"issue":"23","key":"zoi210008r36","doi-asserted-by":"publisher","first-page":"2187","DOI":"10.1056\/NEJMoa2004325","article-title":"Oral relugolix for androgen-deprivation therapy in advanced prostate cancer.","volume":"382","author":"Shore","year":"2020","journal-title":"N Engl J Med"},{"issue":"2","key":"zoi210008r37","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1200\/jco.2016.34.2_suppl.178","article-title":"The RADICAL-PC trial","volume":"34","author":"Pinthus","year":"2016","journal-title":"J Clin Oncol"},{"issue":"6","key":"zoi210008r38","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1097\/JU.0000000000000714","article-title":"Cardiovascular risk in men with prostate cancer: insights from the RADICAL PC Study.","volume":"203","author":"Leong","year":"2020","journal-title":"J Urol"},{"issue":"2","key":"zoi210008r39","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.urolonc.2019.02.010","article-title":"Androgen deprivation therapy and cardiovascular disease.","volume":"38","author":"Melloni","year":"2020","journal-title":"Urol Oncol"},{"issue":"21","key":"zoi210008r40","doi-asserted-by":"publisher","first-page":"2359","DOI":"10.1001\/jama.2011.1745","article-title":"Association of androgen deprivation therapy with cardiovascular death in patients with prostate cancer: a meta-analysis of randomized trials.","volume":"306","author":"Nguyen","year":"2011","journal-title":"JAMA"},{"issue":"48","key":"zoi210008r41","doi-asserted-by":"publisher","first-page":"3889","DOI":"10.1093\/eurheartj\/ehz766","article-title":"A population-based study of cardiovascular disease mortality risk in US cancer patients.","volume":"40","author":"Sturgeon","year":"2019","journal-title":"Eur Heart J"},{"key":"zoi210008r42","article-title":"The emerging and promising role of care for cardiometabolic syndrome in prostate cancer.","author":"Tanaka","journal-title":"J Am Coll Cardiol CardioOnc"},{"issue":"4","key":"zoi210008r43","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1093\/cid\/cix359","article-title":"Risk of acute myocardial infarction among hepatitis C virus (HCV)-positive and HCV-negative men at various lipid levels: results from ERCHIVES.","volume":"65","author":"Butt","year":"2017","journal-title":"Clin Infect Dis"},{"issue":"1","key":"zoi210008r44","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1007\/s11606-016-3775-2","article-title":"Comparing VA and non-VA quality of care: a systematic review.","volume":"32","author":"O\u2019Hanlon","year":"2017","journal-title":"J Gen Intern Med"},{"issue":"1","key":"zoi210008r45","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1097\/MLR.0b013e3181f53575","article-title":"Systematic review: comparison of the quality of medical care in Veterans Affairs and non-Veterans Affairs settings.","volume":"49","author":"Trivedi","year":"2011","journal-title":"Med Care"},{"key":"zoi210008r19","unstructured":"Prostate Cancer Foundation. PCF & the VA: shepherding extraordinary care. Accessed November 1, 2019. https:\/\/www.pcf.org\/va-partnership\/"}],"container-title":["JAMA Network Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/articlepdf\/2776753\/sun_2021_oi_210008_1613516840.53444.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,2,24]],"date-time":"2021-02-24T12:24:54Z","timestamp":1614169494000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/fullarticle\/2776753"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2,24]]},"references-count":45,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,2,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamanetworkopen.2021.0070","relation":{},"ISSN":["2574-3805"],"issn-type":[{"value":"2574-3805","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,2,24]]}}}